Laman UtamaBIOG-B • STO
add
BioGaia AB
Tutup sebelumnya
kr 105.80
Julat hari
kr 106.00 - kr 107.00
Julat tahun
kr 94.75 - kr 136.60
Permodalan pasaran
10.31B SEK
Bilangan Purata
406.47K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
STO
Berita pasaran
Barron's
4 jam lalu
How High Can the S&P 500 Go? The Math Behind Wall Street’s Sky-High Price
Targets.
0.35%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (SEK) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 303.97J | -4.32% |
Perbelanjaan pengendalian | 124.96J | 7.14% |
Pendapatan bersih | 36.60J | -63.94% |
Margin untung bersih | 12.04 | -62.32% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 103.72J | -16.66% |
Kadar cukai berkesan | 22.09% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (SEK) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.11B | -23.26% |
Jumlah aset | 1.90B | -17.33% |
Jumlah liabiliti | 285.12J | -10.62% |
Jumlah ekuiti | 1.62B | — |
Syer tertunggak | 101.16J | — |
Harga kepada buku | 6.61 | — |
Pulangan pada aset | 12.79% | — |
Pulangan pada modal | 15.24% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (SEK) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 36.60J | -63.94% |
Tunai daripada operasi | 100.03J | 1.06% |
Tunai daripada pelaburan | -2.81J | 68.53% |
Tunai daripada pembiayaan | 14.23J | 939.29% |
Perubahan bersih dalam tunai | 106.86J | 28.81% |
Aliran tunai bebas | 74.41J | 104.18% |
Perihal
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
Diasaskan
1990
Tapak web
Pekerja
222
